OmniVision Integrated Circuits Group, Inc. reported the issuance of 128,832 new A shares in May 2026, bringing the total number of issued A shares (excluding treasury shares) to 1,204,585,536. Issued H shares remained unchanged at 50,741,100, while treasury shares held steady at 6,002,763.

The month’s increase was driven mainly by the exercise of employee stock options: • 2023 First Phase Stock Option Incentive Plan: 48,205 new A shares issued at an exercise price of RMB 78.01. • 2023 Second Phase Stock Option Incentive Plan: 80,566 new A shares issued at the same exercise price.

Together, option exercises contributed 128,771 new shares and raised RMB 10.05 million in cash proceeds.

A further 61 A shares were issued upon conversion of the company’s RMB-denominated convertible bonds due 27 December 2026, converted at RMB 159.12 per share. After the conversion, RMB 2.43 billion in principal amount of the bonds remained outstanding and could be exchanged for up to 15.29 million additional A shares.

As of 31 May 2026, OmniVision’s authorised share capital comprised 1,210,588,299 A shares and 50,741,100 H shares, totalling 1,261,329,399 shares. The H-share public float stood at 4.04%, representing a market value of HK$4.89 billion and meeting the Hong Kong Stock Exchange’s minimum requirement.

Outstanding equity instruments include 28.65 million unexercised options across the 2023 and 2025 stock option plans, with the 2025 plan accounting for 19.98 million of the total. No changes were recorded in treasury shares, warrants, or other share-linked instruments during the period.